// App-Quantinova.ai

: MANAGEMENT OF TYPE 2 HEPARIN-INDUCED THROMBOCYTOPENIA PRIOR TO HEARTMATE 3 LEFT VENTRICULAR ASSIST DEVICE IMPLANTATION: A CASE SERIES

Researchers

Presenter

  • Syed Yaseen Naqvi

Principal Investigators

  • Jacqueline Morris

  • Jennifer Falvey

  • Igor Gosev

  • Bryan Barrus

  • Himabindu Vidula

Medical Centers

  • University of Rochester Medcal Center, Rochester, NY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Central Nervous System (CNS)

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

Disease

  • Non-Ischemic cardiomyopathy

  • Arrhythmia

  • Pulmonary embolism

  • Cardiogenic shock

  • Thrombocytopenia

  • Heart muscle disease

  • Venous thrombosis

  • Stroke

Biomarkers

  • Platelet Factor 4

Drug/Treatment

  • Fondaparinux sodium

  • Bivalirudin

  • Argatroban

  • Warfarin

  • Heparin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved